Answers are grounded in this paper and cite their sources.
At present, randomised clinical trials to evaluate metformin’s clinical impact on healthy ageing are limited. Here, we review the role of metformin and its potential to reduce cardiovascular events in the healthy elderly.
No takes yet. Share an insight, caveat, or question.
Dan Xu (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: